Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Biochem ; 170(5): 631-637, 2021 Dec 28.
Article in English | MEDLINE | ID: mdl-34270745

ABSTRACT

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) that harbours a tyrosine kinase domain in its intracellular region and is expressed in both central and peripheral nervous systems. RTKs are activated upon ligand binding and receptor clustering; however, ALK remains an orphan receptor despite its pathological significance, especially in malignancy. Recent biochemical work showed that heparan sulphate (HS), an unbranched sulphated glycan, acts as a ligand for and activates ALK. Here, we show that dermatan sulphate (DS, chondroitin sulphate B) directly interacts with the extracellular N-terminal region of ALK as well as HS. The tetrasaccharide of DS was required and was sufficient for inducing autophosphorylation of ALK at tyrosine 1604, a marker for activated ALK. Interestingly, longer oligosaccharides caused enhanced activation of ALK, as was the case for HS. Our results provide a novel example of glycans as signalling molecules and shed light on the pathophysiological roles of ALK.


Subject(s)
Anaplastic Lymphoma Kinase/agonists , Anticoagulants/pharmacology , Dermatan Sulfate/pharmacology , Neoplasms/pathology , Anaplastic Lymphoma Kinase/metabolism , Anticoagulants/chemistry , Cell Line , Dermatan Sulfate/chemistry , Enzyme Activation , Humans , Ligands , Neoplasms/drug therapy , Neoplasms/metabolism , Phosphorylation , Protein Binding , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...